Cadence Biomedical

company

About

Cadence Biomedical is an early-stage medical device company that focuses on mobility impairments.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$1.20M
Industries
Biotechnology,Health Care,Medical Device,Pharmaceutical
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life.

Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings.

The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$3.05M
Cadence Biomedical has raised a total of $3.05M in funding over 2 rounds. Their latest funding was raised on Jun 25, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 25, 2015 Series B $1.20M 1 Detail
Apr 26, 2012 Series A $1.10M 1 Detail
Jan 20, 2012 Series Unknown $750K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cadence Biomedical is funded by 2 investors. BioPacific Ventures and Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
BioPacific Ventures Series B
Keiretsu Forum Series A